Fu P - Search Results

1

OTUB2 Promotes Cancer Metastasis via Hippo-Independent Activation of YAP and TAZ.

Zhang Z, Du J, Wang S, Shao L, Jin K, Li F, Wei B, Ding W, Fu P, van Dam H, Wang A, Jin J, Ding C, Yang B, Zheng M, Feng XH, Guan KL, Zhang L. Zhang Z, et al. Among authors: fu p. Mol Cell. 2019 Jan 3;73(1):7-21.e7. doi: 10.1016/j.molcel.2018.10.030. Epub 2018 Nov 21. Mol Cell. 2019. PMID: 30472188 Free article.

2

Prognostic value of preoperative inflammatory markers in Chinese patients with breast cancer.

Yao M, Liu Y, Jin H, Liu X, Lv K, Wei H, Du C, Wang S, Wei B, Fu P. Yao M, et al. Among authors: fu p. Onco Targets Ther. 2014 Sep 26;7:1743-52. doi: 10.2147/OTT.S69657. eCollection 2014. Onco Targets Ther. 2014. PMID: 25328407 Free PMC article.

3

The neutrophil lymphocyte ratio is associated with breast cancer prognosis: an updated systematic review and meta-analysis.

Wei B, Yao M, Xing C, Wang W, Yao J, Hong Y, Liu Y, Fu P. Wei B, et al. Among authors: fu p. Onco Targets Ther. 2016 Sep 8;9:5567-75. doi: 10.2147/OTT.S108419. eCollection 2016. Onco Targets Ther. 2016. PMID: 27660475 Free PMC article. Review.

4

Research on correlations of miR-585 expression with progression and prognosis of triple-negative breast cancer.

Yao M, Wang S, Chen L, Wei B, Fu P. Yao M, et al. Among authors: fu p. Clin Exp Med. 2022 May;22(2):201-207. doi: 10.1007/s10238-021-00704-0. Epub 2021 Apr 7. Clin Exp Med. 2022. PMID: 33826023

5

miR-27b-3p inhibits proliferation and potentially reverses multi-chemoresistance by targeting CBLB/GRB2 in breast cancer cells.

Chen D, Si W, Shen J, Du C, Lou W, Bao C, Zheng H, Pan J, Zhong G, Xu L, Fu P, Fan W. Chen D, et al. Among authors: fu p. Cell Death Dis. 2018 Feb 7;9(2):188. doi: 10.1038/s41419-017-0211-4. Cell Death Dis. 2018. PMID: 29416005 Free PMC article.

6

Interleukin-22 promotes triple negative breast cancer cells migration and paclitaxel resistance through JAK-STAT3/MAPKs/AKT signaling pathways.

Wang S, Yao Y, Yao M, Fu P, Wang W. Wang S, et al. Among authors: fu p. Biochem Biophys Res Commun. 2018 Sep 10;503(3):1605-1609. doi: 10.1016/j.bbrc.2018.07.088. Epub 2018 Jul 23. Biochem Biophys Res Commun. 2018. PMID: 30072097

7

Lin28 mediates paclitaxel resistance by modulating p21, Rb and Let-7a miRNA in breast cancer cells.

Lv K, Liu L, Wang L, Yu J, Liu X, Cheng Y, Dong M, Teng R, Wu L, Fu P, Deng W, Hu W, Teng L. Lv K, et al. Among authors: fu p. PLoS One. 2012;7(7):e40008. doi: 10.1371/journal.pone.0040008. Epub 2012 Jul 9. PLoS One. 2012. PMID: 22808086 Free PMC article.

8

Novel targeted therapies to overcome trastuzumab resistance in HER2-overexpressing metastatic breast cancer.

Huang Y, Fu P, Fan W. Huang Y, et al. Among authors: fu p. Curr Drug Targets. 2013 Jul;14(8):889-98. doi: 10.2174/13894501113149990161. Curr Drug Targets. 2013. PMID: 23531110 Review.

9

Knockdown of dual specificity phosphatase 4 enhances the chemosensitivity of MCF-7 and MCF-7/ADR breast cancer cells to doxorubicin.

Liu Y, Du F, Chen W, Yao M, Lv K, Fu P. Liu Y, et al. Among authors: fu p. Exp Cell Res. 2013 Dec 10;319(20):3140-9. doi: 10.1016/j.yexcr.2013.08.023. Epub 2013 Sep 3. Exp Cell Res. 2013. PMID: 24012960

10

EIF5A2 is a novel chemoresistance gene in breast cancer.

Liu Y, Du F, Chen W, Yao M, Lv K, Fu P. Liu Y, et al. Among authors: fu p. Breast Cancer. 2015 Nov;22(6):602-7. doi: 10.1007/s12282-014-0526-2. Epub 2014 Mar 18. Breast Cancer. 2015. PMID: 24638963

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

2,884 results

Search Page